Pharmaceuticals
The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know
more?
You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.
The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health.
Show Less
Read more
GBI Research, the leading business intelligence provider, has released its latest research, “Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency...
September
2012
FROM
EUR 2,677USD 3,500GBP 2,256AUD 3,724JPY 342,774SEK 23 176CHF 3'293CAD 3,639
GBI Research's new report, “Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market”, presents various tools and strategies which...
September
2012
FROM
EUR 2,677USD 3,500GBP 2,256AUD 3,724JPY 342,774SEK 23 176CHF 3'293CAD 3,639
Depilatories in Kazakhstan
The media continues to play an important role in shaping women’s attitudes towards beauty and the importance of maintaining a well-groomed appearance as the importance of looking good and feeling attractive...
September
2012
FROM
EUR 688USD 900GBP 580AUD 958JPY 88,142SEK 5 959CHF 847CAD 936
Healthcare, Regulatory and Reimbursement Landscape - Taiwan
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Healthcare, Regulatory and Reimbursement Landscape...
September
2012
FROM
EUR 1,526USD 1,995GBP 1,286AUD 2,123JPY 195,381SEK 13 210CHF 1'877CAD 2,074
Global Hypertension Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Hypertension Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Hypertension...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Parkinson's Disease Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Parkinson's Disease Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Parkinson's...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Overactive Bladder Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Overactive Bladder Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Overactive...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Ovarian Cancer Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Ovarian Cancer Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Ovarian Cancer...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Pancreatic Cancer Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Pancreatic Cancer Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Pancreatic...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Myocardial Infarction Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Myocardial Infarction Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Myocardial...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Neutropenia Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Neutropenia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Neutropenia market....
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Hepatitis Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Hepatitis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Hepatitis market....
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Neuralgia Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Neuralgia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Neuralgia market....
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Neuropathic Pain Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Neuropathic Pain Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Neuropathic...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global HIV Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global HIV Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global HIV market. It covers...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Insomnia Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Insomnia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Insomnia market....
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Infertility Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Infertility Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Infertility market....
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Oesophageal Cancer Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Oesophageal Cancer Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Oesophageal...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Osteoporosis Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Osteoporosis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Osteoporosis...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541
Global Idiopathic Pulmonary Fibrosis Drug Pipeline Capsule - 2012 Update
Fore Pharma's latest report 'Global Idiopathic Pulmonary Fibrosis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global...
September
2012
FROM
EUR 398USD 520GBP 335AUD 553JPY 50,926SEK 3 443CHF 489CAD 541